Dr. Mark Ranalli
Claim this profileNationwide Children's Hospital
Expert in Cancer
Expert in Brain Tumor
70 reported clinical trials
123 drugs studied
About Mark Ranalli
Education:
- Obtained MD from The Ohio State University College of Medicine in 2006.
- Completed Residency in Pediatrics at Nationwide Children's Hospital (2006-2009).
- Undertook Fellowship in Pediatric Cardiology at Nationwide Children's Hospital (2009-2012).
Experience:
- Currently serving as a Pediatric Cardiologist at Nationwide Children's Hospital.
Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Brain Tumor
Global LeaderStage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Mark Ranalli is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Mark Ranalli
Clinical Trial Related7 years of experience running clinical trials · Led 70 trials as a Principal Investigator · 29 Active Clinical TrialsTreatments Mark Ranalli has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Nivolumab
- Temozolomide
- Vincristine Sulfate
Breakdown of trials Mark Ranalli has run
Cancer
Brain Tumor
Neuroblastoma
Brain Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Ranalli specialize in?
Mark Ranalli focuses on Cancer and Brain Tumor. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage I.
Is Mark Ranalli currently recruiting for clinical trials?
Yes, Mark Ranalli is currently recruiting for 23 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Mark Ranalli has studied deeply?
Yes, Mark Ranalli has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Mark Ranalli?
Apply for one of the trials that Mark Ranalli is conducting.
What is the office address of Mark Ranalli?
The office of Mark Ranalli is located at: Nationwide Children's Hospital, Columbus, Ohio 43205 United States. This is the address for their practice at the Nationwide Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.